Skip to main content
Premium Trial:

Request an Annual Quote

ABI Names 11 Participants for Its Gene Expression Service Provider Program

NEW YORK, Feb. 9 (GenomeWeb News) - Applied Biosystems has named 11 companies and academic centers in North America, Europe, and Asia to be part of its Advanced Gene Expression Service Provider Program, the company said today.

 

Program members will offer ABI's microarray gene-expression tools and services, including microarrays for human, mouse, and rat genes to "enhance service providers' business offerings," ABI said. The program also includes technical support that "is expected to enhance [partners'] ability to deliver ... gene expression services to clients."

 

Additionally, partners will receive data-analysis and marketing support from ABI, as well as access to the company's Panther protein classification system, marketing collateral material development, and educational seminars, the company said.

 

The centers joining ABI's program are: Bionomics Research and Technology Center at the University of Medicine and Dentistry of New Jersey and Rutgers University in New Jersey; Geneservice Limited in the UK; Genome Express in France; IMGM Laboratories in Germany; Labindia in India; Macrogen in South Korea; the Center for Medical Research at the Medical University in Graz, Austria; Ming Shin Biotech in Taiwan; Trinity College in Dublin, Ireland; the Norwegian Microarray Consortium at the University of Bergen, Norway; and the Vanderbilt Shared Microarray Resource in Nashville, Tenn.

 

Researchers that participate in the services will have the option to validate data from ABI arrays using the company's TaqMan gene expression assays and Real-Time PCR Systems, ABI said.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.